Chinese company targets global sales with quick COVID-19 tests | Inquirer News

Chinese company targets global sales with quick COVID-19 tests

/ 07:18 PM September 29, 2020

flash

This photo taken on September 27, 2020 shows technicians in a research and development lab at Chinese biotech company Coyote, which developed the Flash 20, a fast test for the COVID-19 coronavirus in Beijing. AFP

BEIJING A Chinese company is entering the global race to help defeat the coronavirus, promising its testing machine will return results faster than a lab and more reliably than at-home screening kits.

The Flash 20 “is currently the fastest machine in the world for PCR tests for the new coronavirus”, says Sabrina Li, founder of the company Coyote.

Article continues after this advertisement

PCR tests are the industry standard and a major weapon against a pandemic that has now killed more than a million people and eviscerated the global economy.

FEATURED STORIES

As governments scramble to develop adequate response systems, Li is targeting global sales.

Already used at hospitals and airports in China, the contraption can process four samples in one go and deliver results in just half an hour.

Article continues after this advertisement

It has been certified by the European Union and Australia, and Coyote is seeking similar status from the United States and the World Health Organization.

Article continues after this advertisement

Testing has been hailed as one of the best weapons to contain the pandemic and other researchers are also on the quest to find the fastest method.

Article continues after this advertisement

On Monday US President Donald Trump announced the distribution of 150 million rapid coronavirus tests that can deliver a result in 15-30 minutes.

Different to PCR tests, these rapid diagnostic kits offer a quick turnaround but are less sensitive and more likely to return false negatives.

Article continues after this advertisement

The makers of the Flash 20 say their machine, about the size of a printer, is not only fast but extremely reliable.

Past experience with major disease outbreaks helped Coyote respond quickly this time around, the company said.

The SARS epidemic of 2003-2004 jolted China’s biotechnology sector and led to a great “reorganization” in the way the industry works, Zang Yuepeng, Coyote’s technical manager responsible for the Flash 20, told AFP.

So when COVID-19 emerged in the central Chinese city of Wuhan late last year, Coyote was able to design the machine and “very quickly put this product on the market”.

Between February and July, 500,000 tests were carried out in China by the authorities using the Flash 20, and the results were 97 percent the same as those returned by conventional PCR testing in a lab.

The company can currently produce only 500 a month but is hoping to double that number by the end of the year.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The main challenge, Coyote said, will be making enough machines to meet what it hopes will be a huge demand.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: 2019-nCoV, China, Coronavirus, COVID-19, Flash 20, Health, NcoV, nCoV update, News, Outbreak, pandemic, Virus, world, world news, Wuhan

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.